Citius Pharmaceuticals Inc (NASDAQ: CTXR), a Cranford, New Jersey, company, gained to close at $2.01 Wednesday after gaining $0.06 (3.08%) on volume of 4,916,190 shares. The stock ranged from a high of $2.12 to a low of $1.92 while Citius’s market cap now stands at $293,418,652.
About Citius Pharmaceuticals Inc
Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.